Skip to main content
Fig. 7 | Translational Neurodegeneration

Fig. 7

From: Transplantation of bone marrow derived macrophages reduces markers of neuropathology in an APP/PS1 mouse model

Fig. 7

Treatment with BM-M resulted in reduced levels in inflammation markers in the hippocampus of APP/PS1 treated mice. mRNA expression of inflammation markers PTGER2, IFN-γ, IL-6 and IL-10 was reduced in the hippocampus of APP/PS1 which received BM-M (n = 6) compared to PBS injected control group (n = 6). Values were normalized to 36B4 level. Bar graphs display the mean ± SEM (error bars). Statistical significances are represented as *P < 0.05

Back to article page